Do you have trouble sleeping in the morning or in the middle of the night? This can affect your risk of developing dementia.

Published Date: 08 Mar 2023

Along with growing evidence of poor sleep and cognitive impairment, a new study has found an association between three measures of sleep and the risk of developing dementia by age 10. ...

Read Full News

Latest News

TBI History Tied to False-Negative Alzheimer’s Blood Test

FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.

p-Tau217 May Predict Cognitive Decline Years Before Symptoms

Higher plasma p-tau217 levels identified cognitively sound older adults at greater risk for future cognitive impairment up to a decade before symptom onset.

ENTF Stim Boosts Freedom From Disability Post-Stroke

Electromagnetic stimulation combined with physical and occupational therapy is linked to a higher rate of freedom from disability post-stroke than sham, a study shows.

Rituximab Noninferior to Ocrelizumab in Relapsing MS

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows.

FDA Neurology Roundup: June 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

AI Uncovers ‘Invisible’ Cortical Lesions in MS MRI Scans

AI-enhanced analysis of conventional MRI scans reveals thousands of hidden cortical lesions in multiple sclerosis, potentially opening a new window into disease progression.

Todays Updates

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.

Stem Cell Transplant Associated With Better PFS in NKTCL

Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.

Todays Updates

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.

Stem Cell Transplant Associated With Better PFS in NKTCL

Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.

Latest News

FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.

Higher plasma p-tau217 levels identified cognitively sound older adults at greater risk for future cognitive impairment up to a decade before symptom onset.

Electromagnetic stimulation combined with physical and occupational therapy is linked to a higher rate of freedom from disability post-stroke than sham, a study shows.

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows.

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

AI-enhanced analysis of conventional MRI scans reveals thousands of hidden cortical lesions in multiple sclerosis, potentially opening a new window into disease progression.

News All Time

RFK Jr. Seeks to Peek at Americans' Medical Records for Clues on Autism and Vaccines

Some public health leaders have raised doubts that giving access would be legal or even useful

MAHA's Autism Treatments: Camel's Milk, Stem Cell Injections, and Spelling Therapy

Experts say some of the methods may be fraudulent

Primitive Reflexes May Predict Dementia

Two or more frontal release signs in cognitively normal people tied to higher risk of dementia

Brain Institute Halts Research; Parkinson's Deaths Fall; Meet the 'Dementia Rebels'

News and commentary from the world of neurology and neuroscience

Alzheimer's May Be Worse for People Taking Popular Supplement

Glucosamine tied to faster progression in people with established neurodegeneration

Genetic Risk of Autism, ADHD Decreased as Diagnoses Increased

Study offers "new perspective for ongoing debates" about increasing diagnoses, researchers say

Report: Law Firms Cheated in Filing Claims With NFL's Concussion Settlement Fund

The fund was meant to last for 65 years

Ebola's Brain Effects Persist More Than 7 Years After Infection

Many survivors still had neurologic symptoms, most notably memory loss

Alzheimer's and Psilocybin; Migraine and Driving; What New MS Criteria Reveal

News and commentary from the world of neurology and neuroscience

Hospital's Brain Tumor Cluster; Princess's Lung Transplant; Plastic Surgery Deaths

Health news and commentary gathered by MedPage Today staff

Brain Disorders and TBI May Fuel Each Other

Two-way relationships with traumatic brain injury emerge in a large study of veterans

FDA Reverses Course on Neuro Drugs; Omega-3s and Dementia; Brain Death Test Lawsuit

News and commentary from the world of neurology and neuroscience

ALS Testing Expected to Drive Sharp Rise in Clinic Visits

Genetic screening in the wake of new therapies will identify more at-risk relatives

First State Bans Paraquat, a Weed Killer Linked to Parkinson's Disease

The herbicide is used widely in the U.S. but banned in China and Europe

Study Suggests No Link Between Prenatal Tylenol and Risks for Autism, ADHD

Research shows the power of negative control analyses

NFL Star Diagnosed With ALS at 39; 'No Surprises' Windfall; Arizona Plague Scare

Health news and commentary gathered by MedPage Today staff

Recommended News For You

Belzutifan Plus Pembro Approved for Adjuvant RCC

Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC

Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

When it comes to obesity-related cancers, where you shop for food matters

Recommended Articles For You

Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression 

Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know 

The Impact of Microadenoma on Hormonal Health 

Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study sheds light on challenges for women of color after breast cancer surgery

2.

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

3.

Making informed decisions and managing regret after prostate cancer treatment

4.

What Comes After Cancer?

5.

Q&A: When will individuals be able to receive customized cancer vaccines?

1.

Future-Ready Cancer Screening: What Every Clinician Should Know in 2025

2.

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine

3.

Exploring The Causes and Consequences of Low Transferrin Saturation

4.

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy

5.

Erythropoietic Activity Biomarkers in Functional Hematology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part I

2.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

3.

Thromboprophylaxis In Medical Settings

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot